Zai Lab Ltd
(MEX:ZLAB)
MXN
566
0 (0%)
Market Cap: 61.66 Bil
Enterprise Value: 51.50 Bil
PE Ratio: 0
PB Ratio: 3.73
GF Score: 55/100 Zai Lab Ltd at Citi BioPharma Conference Transcript
Sep 08, 2022 / 12:50PM GMT
Release Date Price:
MXN913.56
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director
Everyone, mainly the people on the webcast, but okay. It's a great pleasure to have senior management from Zai Lab here. I've been following Zai Lab since they were a private company back in 2017. In fact, I've been to China a few times to see their operations. So I want to welcome Billy Cho, CFO; Josh Smiley, COO, who just recently joined the company officially, I think August 1.
Joshua L. Smiley
Zai Lab Limited - COO
That's right. Yes.
Questions & Answers
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director
So welcome both of you. I guess at a high level, I think we can just start by a broad strategy question. What is Zai's mission? How are you different from some of your key competitors in the China biotech space? And what's the core investment case for Zai Lab?
Joshua L. Smiley
Zai Lab Limited - COO
Sure. No, thanks, Yigal, and thanks for having us. I think it's pretty
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot